183 related articles for article (PubMed ID: 19337253)
21. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Sakaguchi K; Shiratori Y
Am J Gastroenterol; 2007 Oct; 102(10):2259-64. PubMed ID: 17617203
[TBL] [Abstract][Full Text] [Related]
23. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
24. [Improvement in screening for colorectal cancer associated with the use of immunochemical faecal occult blood test].
Launoy G
Pathol Biol (Paris); 2009 Sep; 57(6):488-92. PubMed ID: 18834677
[TBL] [Abstract][Full Text] [Related]
25. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.
Hughes K; Leggett B; Del Mar C; Croese J; Fairley S; Masson J; Aitken J; Clavarino A; Janda M; Stanton WR; Tong S; Newman B
Aust N Z J Public Health; 2005 Aug; 29(4):358-64. PubMed ID: 16222934
[TBL] [Abstract][Full Text] [Related]
26. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme.
Ciatto S; Martinelli F; Castiglione G; Mantellini P; Rubeca T; Grazzini G; Bonanomi AG; Confortini M; Zappa M
Br J Cancer; 2007 Jan; 96(2):218-21. PubMed ID: 17211476
[TBL] [Abstract][Full Text] [Related]
27. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience.
Zappa M; Castiglione G; Paci E; Grazzini G; Rubeca T; Turco P; Crocetti E; Ciatto S
Int J Cancer; 2001 Apr; 92(1):151-4. PubMed ID: 11279619
[TBL] [Abstract][Full Text] [Related]
28. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
[TBL] [Abstract][Full Text] [Related]
29. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
30. Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia.
Rozen P; Knaani J; Papo N
Eur J Cancer Prev; 1995 Dec; 4(6):475-81. PubMed ID: 8580783
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity and specificity of CT colonography for the detection of colonic neoplasia after positive faecal occult blood testing: systematic review and meta-analysis.
Plumb AA; Halligan S; Pendsé DA; Taylor SA; Mallett S
Eur Radiol; 2014 May; 24(5):1049-58. PubMed ID: 24519111
[TBL] [Abstract][Full Text] [Related]
32. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
33. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.
Wong BC; Wong WM; Cheung KL; Tong TS; Rozen P; Young GP; Chu KW; Ho J; Law WL; Tung HM; Lai KC; Hu WH; Chan CK; Lam SK
Aliment Pharmacol Ther; 2003 Nov; 18(9):941-6. PubMed ID: 14616158
[TBL] [Abstract][Full Text] [Related]
34. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening.
Liedenbaum MH; van Rijn AF; de Vries AH; Dekker HM; Thomeer M; van Marrewijk CJ; Hol L; Dijkgraaf MG; Fockens P; Bossuyt PM; Dekker E; Stoker J
Gut; 2009 Sep; 58(9):1242-9. PubMed ID: 19625276
[TBL] [Abstract][Full Text] [Related]
35. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
36. Experience with haemoccult screening in Hungary. A multicenter trial.
Siba S
Hepatogastroenterology; 1983 Feb; 30(1):27-9. PubMed ID: 6601046
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions.
Castiglione G; Sala P; Ciatto S; Grazzini G; Mazzotta A; Rossetti C; Spinelli P; Bertario L
Eur J Cancer Prev; 1994 Sep; 3(5):399-405. PubMed ID: 8000308
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
[TBL] [Abstract][Full Text] [Related]
39. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
Hundt S; Haug U; Brenner H
Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
